BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu W, Gao W, Deng Y, Yu X, Zhu H. Identification and Development of Long Non-coding RNA Associated Regulatory Network in Pancreatic Adenocarcinoma. Onco Targets Ther 2020;13:12083-96. [PMID: 33262608 DOI: 10.2147/OTT.S265036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang H, Zhang W, Ding J, Hu J, Sun Y, Peng W, Chu Y, Xie L, Mei Z, Shao Z, Xiao Y. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma. Front Immunol 2022;13:970588. [DOI: 10.3389/fimmu.2022.970588] [Reference Citation Analysis]
2 Zhang Y, Fang Y, Ma L, Xu J, Lv C, Deng L, Zhu G. LINC00857 regulated by ZNF460 enhances the expression of CLDN12 by sponging miR-150-5p and recruiting SRSF1 for alternative splicing to promote epithelial-mesenchymal transformation of pancreatic adenocarcinoma cells. RNA Biol 2022;19:548-59. [PMID: 35442145 DOI: 10.1080/15476286.2021.1992995] [Reference Citation Analysis]
3 Gao Y, Liu J, Cai B, Chen Q, Wang G, Lu Z, Jiang K, Miao Y. Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation. Bioengineered 2021;12:10553-67. [PMID: 34854360 DOI: 10.1080/21655979.2021.2000197] [Reference Citation Analysis]
4 Tan P, Chen H, Huang Z, Huang M, Du Y, Li T, Chen Z, Liu Y, Fu W. MMP25-AS1/hsa-miR-10a-5p/SERPINE1 axis as a novel prognostic biomarker associated with immune cell infiltration in KIRC. Mol Ther Oncolytics 2021;22:307-25. [PMID: 34553021 DOI: 10.1016/j.omto.2021.07.008] [Reference Citation Analysis]